Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
TNFRSF9 elevation
i
Other names:
TNFRSF9, TNF Receptor Superfamily Member 9, CD137, Tumor Necrosis Factor Receptor Superfamily Member 9, T-Cell Antigen 4-1BB Homolog, 4-1BB Ligand Receptor, CD137 Antigen, CDw137, ILA, Interleukin-Activated Receptor, Homolog Of Mouse Ly63, Tumor Necrosis Factor Receptor Superfamily, Member 9, Induced By Lymphocyte Activation (ILA), Homolog Of Mouse 4-1BB, Receptor Protein 4-1BB, T Cell Antigen ILA, T-Cell Antigen ILA
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3604
Related biomarkers:
Expression
‹
TNFRSF9 overexpression (2)
TNFRSF9 positive + CD4 positive (1)
TNFRSF9 positive + CD8 positive (1)
TNFRSF9 overexpression (2)
TNFRSF9 positive + CD4 positive (1)
TNFRSF9 positive + CD8 positive (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
TNFRSF9 elevation
Hepatocellular Cancer
TNFRSF9 elevation
Hepatocellular Cancer
sintilimab + Byvasda (bevacizumab biosimilar)
Sensitive: C3 – Early Trials
sintilimab + Byvasda (bevacizumab biosimilar)
Sensitive
:
C3
sintilimab + Byvasda (bevacizumab biosimilar)
Sensitive: C3 – Early Trials
sintilimab + Byvasda (bevacizumab biosimilar)
Sensitive
:
C3
TNFRSF9 elevation
Clear Cell Renal Cell Carcinoma
TNFRSF9 elevation
Clear Cell Renal Cell Carcinoma
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login